Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             32 results found
no title author magazine year volume issue page(s) type
1 Antidepressant action of agomelatine (S 20098) in a transgenic mouse model Barden, Nicholas
2005
29 6 p. 908-916
9 p.
article
2 Antidepressant-elicited changes in gene expression Yamada, Mitsuhiko
2005
29 6 p. 999-1009
11 p.
article
3 Antioxidant properties of propofol and erythropoietin after closed head injury in rats Ozturk, Erdogan
2005
29 6 p. 922-927
6 p.
article
4 Anxiolytic-like effects of ginseng in the elevated plus-maze model: Comparison of red ginseng and sun ginseng Park, Jeong-Hill
2005
29 6 p. 895-900
6 p.
article
5 Attention deficit hyperactivity disorder and borderline personality disorder Davids, Eugen
2005
29 6 p. 865-877
13 p.
article
6 Chronic treatment with sulbutiamine improves memory in an object recognition task and reduces some amnesic effects of dizocilpine in a spatial delayed-non-match-to-sample task Bizot, Jean-Charles
2005
29 6 p. 928-935
8 p.
article
7 Direct-care staff body mass index in a state mental hospital Vieweg, W. Victor R.
2005
29 6 p. 989-991
3 p.
article
8 Editorial Board 2005
29 6 p. CO2-
1 p.
article
9 Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patients de Mendonça Lima, Carlos A.
2005
29 6 p. 952-956
5 p.
article
10 Gamma-aminobutyric acid and mefloquine-induced seizures in mice Amabeoku, George J.
2005
29 6 p. 917-921
5 p.
article
11 Genetic variants in the angiotensin I-converting-enzyme (ACE) and angiotensin II receptor (AT1) gene and clinical outcome in depression Bondy, Brigitta
2005
29 6 p. 1094-1099
6 p.
article
12 Hypothesis: Minimal changes in neural transmission in schizophrenia: Decreased glutamatergic and GABAergic functions in the prefrontal cortex Ohnuma, Tohru
2005
29 6 p. 889-894
6 p.
article
13 Inhibitory effects of long-term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of β-amyloid peptide (1–42) in mice Cho, Jae-Young
2005
29 6 p. 901-907
7 p.
article
14 Initial conditions of psychotropic drug response: Studies of serotonin transporter long promoter region (5-HTTLPR), serotonin transporter efficiency, cytokine and kinase gene expression relevant to depression and antidepressant outcome Rausch, Jeffrey L.
2005
29 6 p. 1046-1061
16 p.
article
15 Introduction Holsboer, Florian
2005
29 6 p. 996-998
3 p.
article
16 Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder Alda, Martin
2005
29 6 p. 1038-1045
8 p.
article
17 Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia du Bois, Teresa M.
2005
29 6 p. 878-888
11 p.
article
18 N400 as an index of semantic expectancies: Differential effects of alcohol and cocaine dependence Ceballos, Natalie A.
2005
29 6 p. 936-943
8 p.
article
19 New drug targets in the signaling pathways activated by antidepressants Páez-Pereda, Marcelo
2005
29 6 p. 1010-1016
7 p.
article
20 Olanzapine-induced leucopenia and neutropenia Stergiou, Vasilis
2005
29 6 p. 992-994
3 p.
article
21 Paradoxical rate-dependent effect of fluoxetine on captivity-induced stereotypies in bank voles Meers, Lieve
2005
29 6 p. 964-971
8 p.
article
22 Patterns of clinical use of antipsychotics in hospitalized psychiatric patients Mauri, Massimo C.
2005
29 6 p. 957-963
7 p.
article
23 Pharmacogenetics in model systems: Defining a common mechanism of action for mood stabilisers Williams, Robin S.B.
2005
29 6 p. 1029-1037
9 p.
article
24 Pharmacogenetics of the serotonin transporter Lesch, Klaus Peter
2005
29 6 p. 1062-1073
12 p.
article
25 Reply to Dr. Schmidt's remarks on the paper of H.M. van Praag “Can stress cause depression?” van Praag, H.M.
2005
29 6 p. 995-
1 p.
article
26 Safety and effectiveness of olanzapine in monotherapy: A multivariate analysis of a naturalistic study Ciudad, Antonio
2005
29 6 p. 944-951
8 p.
article
27 The combined dexamethasone/CRH test as a potential surrogate marker in depression Ising, Marcus
2005
29 6 p. 1085-1093
9 p.
article
28 The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments Serretti, Alessandro
2005
29 6 p. 1074-1084
11 p.
article
29 The related causes in very early morning onset of stroke Kocer, Abdulkadir
2005
29 6 p. 983-988
6 p.
article
30 The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment Reynolds, Gavin P.
2005
29 6 p. 1021-1028
8 p.
article
31 The usefulness of single nucleotide polymorphisms (SNPs) for genetic epidemiological investigation of complex psychiatric diseases Müller-Myhsok, Bertram
2005
29 6 p. 1017-1020
4 p.
article
32 Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: Results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study Novick, Diego
2005
29 6 p. 972-982
11 p.
article
                             32 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands